サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563839

血清学的移植診断の世界市場

Serological Transplant Diagnostics

出版日
ページ情報
英文 161 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.84円
血清学的移植診断の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 161 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血清学的移植診断の世界市場は2030年までに20億米ドルに達する見込み

2023年に11億米ドルと推定される血清学的移植診断の世界市場は、分析期間2023-2030年にCAGR 8.6%で成長し、2030年には20億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである試薬＆アクセサリーは、CAGR 9.2％を記録し、分析期間終了までに16億米ドルに達すると予測されます。システム分野の成長率は、分析期間中CAGR 6.4％と推定されます。

米国市場は推定3億240万米ドル、中国はCAGR12.1％で成長予測

米国の血清学的移植診断市場は、2023年に3億240万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR12.1%を牽引し、2030年までに4億4,670万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.4%と6.5%と予測されています。欧州では、ドイツがCAGR約6.7%で成長すると予測されています。

世界の血清学的移植診断市場- 主要動向と促進要因のまとめ

なぜ移植医療において血清診断が重要なのか？

血清学的移植診断は移植医療において非常に重要であり、ドナーとレシピエントの適合性を確保し、移植片の拒絶反応を防ぐ上で重要な役割を果たしています。これらの診断には、ヒト白血球抗原（HLA）抗体の検査、血液型検査、およびドナーとレシピエント間の免疫学的適合性を評価するためのクロスマッチングが含まれます。末期臓器疾患の増加に伴う臓器移植需要の高まりが、移植成功率と患者の転帰を改善する血清学的診断の採用に拍車をかけています。ドナー特異抗体（DSA）やその他の免疫学的マーカーを早期かつ正確に検出することが重視されているため、これらの検査は臨床医が免疫抑制療法や移植後のケアについて十分な情報に基づいた判断を下すのに役立ち、市場をさらに牽引しています。

技術の進歩は移植における血清学的診断をどのように強化しているか？

技術の進歩は移植における血清学的診断の能力を著しく向上させ、より正確で高感度、自動化されています。HLAタイピングとクロスマッチングのための自動化プラットフォームとマルチプレックスアッセイの開発により、所要時間が短縮され、移植センターの効率が向上しています。フローサイトメトリー、ルミネックス・テクノロジー、次世代シークエンシング（NGS）の使用は、高解像度のHLAタイピングを可能にし、より良いドナーとレシピエントのマッチングを促進し、移植片拒絶反応のリスクを最小限に抑えます。移植診断におけるAIと機械学習アルゴリズムの統合は、予測分析と意思決定支援ツールを提供し、臨床医が移植患者をより効果的に管理するのに役立っています。さらに、非侵襲的診断ツールや無細胞DNA検査の進歩は、移植片拒絶反応をモニタリングする有望なアプローチとして浮上しており、侵襲的な生検の必要性を減らしています。

血清学的移植診断の採用をリードしている市場セグメンテーションは？

血清学的移植診断市場は、検査タイプ、アプリケーション、エンドユーザー、地域によって区分されます。検査タイプには、HLAタイピング、クロスマッチング、抗体スクリーニングが含まれます。HLAタイピングは、適合性の確保と移植拒絶率の低減に重要な役割を果たすため、最も広く採用されています。用途は腎臓、肝臓、心臓、肺、その他の臓器移植に及び、腎臓移植は末期腎疾患の有病率の高さと生体ドナーが利用可能であることから、最大のセグメントとなっています。エンドユーザーには、病院、移植センター、調査研究所、診断研究所が含まれ、迅速で正確な診断結果を求めるニーズから、病院と移植センターが1次調査機関となっています。地理的には、北米と欧州が、高度なヘルスケア・インフラと高い移植率によって血清学的移植診断市場をリードしているが、アジア太平洋は、臓器移植プログラムの増加と医療費の増加によって、高成長市場として浮上しています。

血清学的移植診断市場の成長促進要因は？

血清学的移植診断市場の成長は、臓器移植需要の増加、自動化およびマルチプレックス診断プラットフォームの進歩、免疫マーカーの早期かつ正確な検出への注目の高まりなど、いくつかの要因によってもたらされます。高精度で迅速な結果を提供する高解像度HLAタイピング、抗体スクリーニング、クロスマッチング技術の市場開拓が、移植センターや病院での市場導入を促進しています。非侵襲的診断や個別化免疫抑制療法が重視されるようになったことで、移植後のモニタリングや患者管理における市場規模が拡大しています。高度な血清学的診断によって移植成功率を向上させ、移植片拒絶反応を減少させる方向へのシフトは、市場成長の新たな機会を生み出しています。さらに、次世代血清学的診断、AI主導の予測分析、移植拒絶反応モニタリングのための無細胞DNA検査の研究開発への投資が増加していることも、市場拡大をさらに後押ししています。

調査対象企業の例（注目の18社）

  • Agena Bioscience, Inc.
  • Avioq, Inc.
  • Bag Health Care GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Biocell Medicare
  • Biogenuix Medsystems Pvt. Ltd.
  • Bio-Rad Laboratories, Inc.
  • DIAGAST
  • Grifols SA
  • Hemo bioscience, Inc.
  • Immucor, Inc.
  • Institut de Biotechnologies Jacques Boy S.A.S.
  • Lorne Laboratories Ltd.
  • MTC med. Produkte GmbH
  • Ortho Clinical Diagnostics
  • Quotient Biodiagnostics
  • REAGENS Kft.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Tulip Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP14675

Global Serological Transplant Diagnostics Market to Reach US$2.0 Billion by 2030

The global market for Serological Transplant Diagnostics estimated at US$1.1 Billion in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Reagents & Accessories, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Systems segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$302.4 Million While China is Forecast to Grow at 12.1% CAGR

The Serological Transplant Diagnostics market in the U.S. is estimated at US$302.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$446.7 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global Serological Transplant Diagnostics Market - Key Trends and Drivers Summarized

Why Are Serological Diagnostics Critical in Transplant Medicine?

Serological transplant diagnostics are crucial in transplant medicine, playing a vital role in ensuring donor-recipient compatibility and preventing graft rejection. These diagnostics involve testing for human leukocyte antigen (HLA) antibodies, blood typing, and crossmatching to assess the immunological compatibility between donors and recipients. The rising demand for organ transplants, driven by increasing cases of end-stage organ diseases, is fueling the adoption of serological diagnostics to improve transplant success rates and patient outcomes. The emphasis on early and accurate detection of donor-specific antibodies (DSAs) and other immunological markers is further driving the market, as these tests help clinicians make informed decisions on immunosuppressive therapies and post-transplant care.

How Are Technological Advancements Enhancing Serological Diagnostics in Transplants?

Technological advancements are significantly enhancing the capabilities of serological diagnostics in transplants, making them more accurate, sensitive, and automated. The development of automated platforms and multiplex assays for HLA typing and crossmatching is reducing turnaround times and improving the efficiency of transplant centers. The use of flow cytometry, Luminex technology, and next-generation sequencing (NGS) is enabling high-resolution HLA typing, facilitating better donor-recipient matching and minimizing the risk of graft rejection. The integration of AI and machine learning algorithms in transplant diagnostics is providing predictive analytics and decision support tools, helping clinicians manage transplant patients more effectively. Additionally, advancements in non-invasive diagnostic tools and cell-free DNA testing are emerging as promising approaches for monitoring allograft rejection, reducing the need for invasive biopsies.

Which Market Segments Are Leading the Adoption of Serological Transplant Diagnostics?

The serological transplant diagnostics market is segmented by test type, application, end-user, and region. Test types include HLA typing, crossmatching, and antibody screening, with HLA typing being the most widely adopted due to its critical role in ensuring compatibility and reducing transplant rejection rates. Applications span kidney, liver, heart, lung, and other organ transplants, with kidney transplants being the largest segment due to the high prevalence of end-stage renal disease and the availability of living donors. End-users include hospitals, transplant centers, research laboratories, and diagnostic laboratories, with hospitals and transplant centers being the primary adopters due to the need for rapid and accurate diagnostic results. Geographically, North America and Europe lead the market for serological transplant diagnostics due to advanced healthcare infrastructure and high transplant rates, while Asia-Pacific is emerging as a high-growth market driven by increasing organ transplantation programs and rising healthcare expenditure.

What Are the Key Drivers of Growth in the Serological Transplant Diagnostics Market?

The growth in the serological transplant diagnostics market is driven by several factors, including the increasing demand for organ transplants, advancements in automated and multiplex diagnostic platforms, and the rising focus on early and accurate detection of immunological markers. The development of high-resolution HLA typing, antibody screening, and crossmatching technologies that provide precise and rapid results is driving market adoption among transplant centers and hospitals. The growing emphasis on non-invasive diagnostics and personalized immunosuppressive therapies is expanding the market reach in post-transplant monitoring and patient management. The shift towards improving transplant success rates and reducing graft rejection through advanced serological diagnostics is creating new opportunities for market growth. Additionally, the increasing investments in R&D for next-generation serological diagnostics, AI-driven predictive analytics, and cell-free DNA testing for transplant rejection monitoring are further supporting market expansion.

Select Competitors (Total 18 Featured) -

  • Agena Bioscience, Inc.
  • Avioq, Inc.
  • Bag Health Care GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Biocell Medicare
  • Biogenuix Medsystems Pvt. Ltd.
  • Bio-Rad Laboratories, Inc.
  • DIAGAST
  • Grifols SA
  • Hemo bioscience, Inc.
  • Immucor, Inc.
  • Institut de Biotechnologies Jacques Boy S.A.S.
  • Lorne Laboratories Ltd.
  • MTC med. Produkte GmbH
  • Ortho Clinical Diagnostics
  • Quotient Biodiagnostics
  • REAGENS Kft.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Tulip Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Serological Transplant Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accurate and Reliable Transplant Compatibility Testing Drives Market for Serological Transplant Diagnostics
    • Technological Advancements in HLA Typing and Crossmatching Propel Innovation in Serological Diagnostics
    • Increasing Use of Serological Diagnostics in Kidney, Liver, Heart, and Lung Transplantation Expands Addressable Market Opportunity
    • Growth of Organ Transplantation Programs and Registries Strengthens Business Case for Serological Diagnostics
    • Challenges Related to Limited Availability of Donors and Ethical Issues Pose Market Constraints
    • Focus on Enhancing Sensitivity, Specificity, and Turnaround Time of Serological Tests Drives Market Adoption
    • Emergence of Automated and High-Throughput Serological Testing Platforms Generates New Market Opportunities
    • Rising Demand for Non-Invasive and Minimally Invasive Transplant Diagnostics Boosts Market Potential
    • Shift Towards Personalized Transplant Medicine and Immunogenetics Expands Market Reach
    • Growing Emphasis on Allograft Rejection Monitoring and Post-Transplant Care Spurs Market Innovation
    • Emergence of Serological Diagnostics as a Key Tool for Reducing Graft Rejection Rates Expands Adoption
    • Rising Number of Transplant Centers and Organ Sharing Networks Creates New Opportunities for Serological Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Serological Transplant Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Serological Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Reagents & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Kidney Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Liver Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Heart Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Lung Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Transplant Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Transplant Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Transplant Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Serological Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: India 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Serological Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Serological Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION